The Blue Eye submucosal injection agent has received FDA clearance and is now available in the U.S. The product, manufactured by Korean devicemaker the Standard Company, is used in endoscopic ...
The figure was derived from‘International consensus on the management of large (≥20 mm) non-pedunculated colorectal polyps: A World Endoscopy Organisation Delphi study’; Djinbachian et al, 2023; Under ...
Dublin, April 08, 2026 (GLOBE NEWSWIRE)-- The "Endoscopic Submucosal Dissection Market Size, Share & Trends Analysis Report by Product, Indication, End Use, Region, and Segment Forecasts, 2026-2033" ...
Active ingredient: Dextranomer microspheres 50 mg/mL, sodium hyaluronate 15 mg/mL; gel for submucosal injection. Indication: Treatment of fecal incontinence in patients who have failed conservative ...
Colorectal cancer (CRC) is the second most common cancer in the United States. This highlights the importance of early detection and treatment of precancerous lesions like large polyps. Endoscopy ...
Neuroendocrine tumors (NETs) of the gastrointestinal (GI) tract are a rare and heterogeneous group of malignancies arising from the neuroendocrine cell system. These tumors are more commonly ...
Olympus Europa SE & Co. KG is launching three Endoclot products, two hemostatic agents and a submucosal injection agent, in the Europe, Middle East and Africa (EMEA) region. This new portfolio was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results